GeoVax Labs announces strategic AI integration in support of Trump’s Stargate

GeoVax Labs (GOVX) announced its endorsement of President Donald J. Trump’s Stargate Initiative, “which aims to harness advanced technologies including Artificial Intelligence to strengthen U.S. healthcare, biosecurity, and global innovation leadership.” This announcement aligns with GeoVax’s commitment to leveraging AI across its vaccine and cancer immunotherapy programs to accelerate research, optimize operations, and deliver life-saving solutions, the company says. GeoVac adds, “President Trump’s Stargate Initiative, supported by up to $500 billion in private-sector investment, represents a bold step forward in embracing transformative technologies. GeoVax proudly aligns with this vision, advancing U.S. healthcare innovation and pandemic preparedness.”